BPB Reports
Online ISSN : 2434-432X
Report
The Cases on the Application of Touch Panel Type Screening Check for Early Detection of Dementia Conducted at a Community Pharmacy Near a Community Medical Hospital to an Advanced Treatment Hospital
Hiroshi AkuraMamiko KaiYoshio SodaTakafumi NakanoToshinobu HayashiHitoshi IidaKoji OgomoriHiroaki KawasakiMasanobu SonodaMasashi TakahashiTakashi Egawa
著者情報
ジャーナル オープンアクセス HTML

2022 年 5 巻 3 号 p. 70-73

詳細
抄録

The purpose of this study is to construct the consultation system based on the touch panel type screening check for dementia (TPCD) results from a pharmacy to psychiatric specialists at an advanced treatment hospital, and to evaluate the effectiveness of resulting in dementia diagnosis. We herein report three cases that demonstrate the significance of TPCD in the course of study. Cases 1 was successful case from a 78-year-old man in which pharmacists recommended individuals scored 11 on the TPCD to visit psychiatrists at Fukuoka University Hospital, an advanced medical hospital, based on the results of TPCD. He was practically diagnosed with mild cognitive impairment (MCI). Cases 2 was partially successful case from a 78-year-old woman. Her TPCD score resulted only 9. The pharmacist effectively utilized tracing report to notify the patient’s cardiologist about the results of the TPCD performed at the pharmacy as she wished. On the other hand, Case 3 showed that patient whose TPCD score resulted 2 could receive no treatment due to advanced stage of dementia despite our consulting with family doctor based on the TPCD scores. These cases suggest that the pharmacy near an advanced medical hospital should play a role to provide accessibility between the patients with suspected dementia and psychiatric specialists and make opportunities to consult specialists earlier before progressing towards a dementia following MCI collaborated with community interprofessionals.

著者関連情報
© 2022 The Pharmaceutical Society of Japan

BPB Reports applies the Creative Commons Attribution (CCBY) license to works we published. The license was developed to facilitate open access - namely, free immediate access to, and unrestricted reuse of, original works to all types. Under this license, authors agree to make articles legally available for reuse, without permissions of fees, for virtually any purpose. Anyone may copy, distribute, or reuse these articles, as long as the author and original source are properly cited.
https://creativecommons.org/licenses/by/4.0/
前の記事
feedback
Top